Suchergebnisse - "Redd, Robert"

PubPharm (92)

1

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

enthalten in: bioRxiv.org | 2024

von Nadeem, O. | Aranha, M. | Redd, R. | +19

2

Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma

enthalten in: HemaSphere | 2024

von Merryman, R. | Rhoades, J. | Xiong, K. | +17

3

Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population

enthalten in: Blood advances | 2024

von Lee, D. | El-Khoury, H. | Tramontano, A. | +13

4

Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST) : Protocol for a Randomized Controlled Pilot Trial

enthalten in: JMIR research protocols | 2024

von Lee, D. | O'Donnell, E. | Raje, N. | +7

5

Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP

enthalten in: Leukemia & lymphoma | 2024

von Nemec, R. | Scherrer-Crosbie, M. | Abramson, J. | +16

6

Ivabradine in the management of elevated resting heart rate associated with mediastinal radiation therapy

enthalten in: Heart rhythm | 2024

von Itzhaki Ben Zadok, O. | Groarke, J. | Caron, J. | +5

7

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

enthalten in: Annals of hematology | 2024

von Merryman, R. | Redd, R. | Freedman, A. | +22

8

Combined analysis of the impact of second-generation BTK inhibitors on patient outcomes

enthalten in: Leukemia & lymphoma | 2023

von Redd, R. | Ford, J. | Lei, M. | +2

9

Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma

enthalten in: Cancer research communications | 2023

von Mouhieddine, T. | Nzerem, C. | Redd, R. | +15

10

Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing

enthalten in: STAR protocols | 2023

von Ten Hacken, E. | Gruber, M. | Hernández-Sánchez, M. | +6

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]